Journal
CURRENT HYPERTENSION REPORTS
Volume 15, Issue 3, Pages 224-231Publisher
SPRINGER
DOI: 10.1007/s11906-013-0334-7
Keywords
Blood pressure; BP; Hypertension; Obesity; Child; Adolescent; Body mass index; BMI; Target organ damage; Comorbidity; Treatment; Bariatric surgery; Lifestyle changes
Categories
Funding
- Novartis
- Pfizer
- American Society of Hypertension
Ask authors/readers for more resources
The obesity epidemic has become a common concern among pediatricians, with an estimated 32 % of US children and adolescents classified as overweight and 18 % as obese. Along with the increase in obesity, a growing body of evidence demonstrates that chronic diseases, such as Type 2 diabetes, primary hypertension, and hyperlipidemia, once thought to be confined solely to adulthood, are commonly seen among the obese in childhood. Following a brief summary of the diagnosis and evaluation of hypertension in obese children and adolescents, this review will highlight recent research on the treatment of obesity-related hypertension. Pharmacologic and non-pharmacologic treatment will be discussed. Additionally, current and emerging therapies for the primary treatment of obesity in children and adolescents, which have been gaining in popularity, will be reviewed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available